Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients With Uveal Melanoma Treated With Proton Beam Therapy.

导出原文传递

翻译打印收藏纠错

作者： Howard J,Lee ^[1] ; Andrew,Stacey ^[2] ; Todd R,Klesert ^[3] ; Craig,Wells ^[3] ; Alison H,Skalet ^[4] ; Charles,Bloch ^[5] ; Angela,Fung ^[6] ; Stephen R,Bowen ^[7] ; Tony P,Wong ^[6] ; Dean,Shibata ^[8] ; Lia M,Halasz ^[5] ; Ramesh,Rengan ^[5]

作者单位： Duke University School of Medicine, Durham, North Carolina. Electronic address: howard.j.lee@duke.edu. ^[1] Department of Ophthalmology, University of Washington School of Medicine, Seattle, Washington. ^[2] Vitreoretinal Associates of Washington, Seattle, Washington. ^[3] Casey Eye Institute, Oregon Health and Science University, Portland, Oregon; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon. ^[4] Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington. ^[5] Seattle Cancer Care Alliance Proton Therapy Center, Seattle, Washington. ^[6] Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington; Department of Radiology, University of Washington School of Medicine, Seattle, Washington. ^[7] Department of Radiology, University of Washington School of Medicine, Seattle, Washington. ^[8]